Sensitivity of FRAMINGHAM, PROCAM and SCORE models in Turkish people with Type 2 diabetes: comparison of three cardiovascular risk calculations
- 4 May 2015
- journal article
- research article
- Published by Taylor & Francis in Contemporary Nurse
- Vol. 50 (2) , 1-13
Abstract
Purpose: To determine the cardiovascular risk factors according to the Framingham, PROCAM and SCORE models, to evaluate the 10-year cardiovascular disease (CVD) risk factors, and to compare the suitability of different models in Turkish Type 2 diabetes patients. Methods: Risk factors and the 10-year CVD risk in 265 patients were evaluated using three risk models. Measurements included blood pressure, weight, height, waist and hip circumferences. Cholesterol, triglycerides, fasting and postprandial plasma glucose and HbA1c were measured. Low-, moderate- and high-risk groups were determined according to the three risk calculations. Results: Hypertension, obesity and no exercise, dyslipidemia and high HbA1c in women, and excessive cigarette/alcohol consumption, increased weight, dyslipidemia and high HbA1c in men were crucial. Men were in the moderate-risk group according to three risk models. Women were in the medium-risk group according to the Framingham and PROCAM risks and in the low-risk group according to the SCORE. Conclusion: Results estimating the 10-year CVD according to the three risk models were inconsistent. More sensitive CVD risk calculators are needed. Discussion and practice implications: Our results could guide diabetes specialists in identifying gender-specific risks and designing preventive interventions.Keywords
This publication has 31 references indexed in Scilit:
- Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adultsEuropean Journal of Epidemiology, 2013
- Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohortBritish Journal of General Practice, 2012
- Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic reviewHeart, 2011
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateJACC, 2011
- Prediction of Coronary Heart Disease Risk in a General, Pre-Diabetic, and Diabetic Population During 10 Years of Follow-up: Accuracy of the Framingham, SCORE, and UKPDS Risk FunctionsDiabetes Care, 2009
- ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in AdultsJACC, 2009
- Development and Validation of a Total Coronary Heart Disease Risk Score in Type 2 Diabetes MellitusThe American Journal of Cardiology, 2008
- Predicted risk of coronary heart disease among persons with type 2 diabetesCoronary Artery Disease, 2007
- Framingham, SCORE, and DECODE Risk Equations Do Not Provide Reliable Cardiovascular Risk Estimates in Type 2 DiabetesDiabetes Care, 2007
- Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic reviewHeart, 2006